T. Rowe Price (TROW): Director received 462.18 shares
Alan D Wilson, Director at T. Rowe Price, reported a grant / award of 462.18 shares.
- 462.18
- Shares · @ $114.38
- Traded
- Jun 29, 2026
- Filed
- Jul 1, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
The company's last weighty Form 8-K report up to this date: changed a top executive or board member, 45 days earlier (May 15, 2026). The first one after it: reported its results, 32 days later (Jul 31, 2026).
- Company filing · Form 8-K · ResultsReported its results
- 5% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- InsiderOfficer sold ~$308K of TROW shares in the open market
- Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 15, 2026, the Board of Directors (the “Board”) of T. Rowe Price Group, Inc. (the “Company”) approved the appointment of Eric L. Veiel to become the President, Co-Head of Global Investments and Chief Investment Officer of the Company, effective immediately.”
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for T. Rowe Price
For T. Rowe Price, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TROW page.
How this filing works
Explore the data
Common questions
Which T. Rowe Price (TROW) insider traded, and how much?
Alan D Wilson, Director at T. Rowe Price, reported a grant / award of 462.18 shares. At $114.38.
When did it happen, and when was it made public?
Traded: Jun 29, 2026. Filed: Jul 1, 2026. That is 2 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about T. Rowe Price recently?
For T. Rowe Price, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the TROW page.
Does this mean TROW stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at T. Rowe Price
- SEC Form 4Aug 26, 2026
- SEC Form 13F-HRAug 17, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRJul 24, 2026
Everything OQRO holds on this company is on its TROW page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
